Pulitzer Prize-winning journalist John Carreyrou's Bad Blood is a riveting exposé that traces the breathtaking rise and collapse of the multibillion-dollar biotech startup Theranos.
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as "the female Steve Jobs": a brilliant Stanford dropout whose startup “unicorn” promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.7 billion. There was just one problem: The technology didn’t work. Rigorously reported and fearlessly written, Bad Blood is a gripping story of the biggest corporate fraud since Enron—a tale of ambition and hubris set amid the bold promises of Silicon Valley.
Join John Carreyrou as he sits down in conversation with Julia Angwin, editor-in-chief and founder of The Markup, to discuss one of the 21st century's defining scandals with the master journalist who chronicled it from the bottom to the top.
The event will be introduced by Latha Poonamallee, associate professor of management and social innovation at the Milano School of Policy, Management, and Environment at The New School.